Location
Boston, MA
Holdings as of
9/30/2025
Date filed
11/14/2025
Form type
13F-HR
Num holdings
21
Total value ($000)
$1,506,676
Net value change ($000)
+707,411 (88.5%)
New positions
2
Sold out positions
4
Turnover %
37.7%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/14/2025 Next filing: 2/17/2026 SEC filing

Snapshot: Change Analysis

Compared to Q2 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
HTFL 419,005 NEW
CDTX 167,482 137.5%
NAMS 110,728 57.0%
OLMA 37,847 129.8%
SVRA 22,705 56.6%
PHVS 21,233 36.5%
UPB 19,102 71.3%
SLDB 10,285 26.7%
KYTX 9,869 95.4%
TNGX 8,896 64.1%
Top Reduces (Value $000, Stocks/ETFs)
NUVL -110,426 -100.0%
IRON -30,902 -100.0%
Mersana Therapeutics, Inc. -2,564 -100.0%
AVIR -1,740 -19.4%
IVVD -1,287 -100.0%
IPSC -1,261 -41.7%
RPID -928 -3.2%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type